Dyne Therapeutics DYN
NASDAQ DYN
$16.21 -0.13 (-0.80%)
At close: Sep 29, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Common Equity (2019 - 2026)

Updated

Dyne Therapeutics' Common Equity was $702.15 million in Q2 2026, up 22.9% from $571.45 million a year earlier but down 18.8% from the prior quarter.

Analysis

Dyne Therapeutics (DYN) Common Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Dyne Therapeutics came in at $972.13 million, up 54.3% from FY2024.

  • Common Equity shows a five-year compound annual growth rate of 23.2% (FY2020 to FY2025).
  • In earlier years, Common Equity was $629.84 million in FY2024 (+589.9%), $91.29 million in FY2023 (-63.8%), $252.36 million in FY2022 (-31.5%) and $368.2 million in FY2021 (+7.5%).
  • Quarterly Common Equity has moved between $91.29 million (Q4 2023) and $972.13 million (Q4 2025) over five years.
  • Compared with a year earlier, Common Equity has increased for three straight quarters, with growth averaging 134.0% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q4 2024 (growth of 589.9%); the worst was Q4 2023 (a decline of 63.8%).
  • Per Business Quant data, DYN's Common Equity in the three quarters before Q2 2026 was $865.06 million (Q1 2026), $972.13 million (Q4 2025) and $691.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 84.97 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.94 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 50.37 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 20.25 Bn
10 Dyne Therapeutics 2.71 Bn 2.71 Bn - 702.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 702.15 Mn
Mar 31, 2026 865.06 Mn
Dec 31, 2025 972.13 Mn
Sep 30, 2025 691.78 Mn
Jun 30, 2025 571.45 Mn
Mar 31, 2025 668.97 Mn
Dec 31, 2024 629.84 Mn
Sep 30, 2024 705.54 Mn
Jun 30, 2024 775.19 Mn
Mar 31, 2024 478.06 Mn
Dec 31, 2023 91.29 Mn
Sep 30, 2023 152.04 Mn
Jun 30, 2023 206.88 Mn
Mar 31, 2023 241.94 Mn
Dec 31, 2022 252.36 Mn
Sep 30, 2022 249.74 Mn
Jun 30, 2022 287.06 Mn
Mar 31, 2022 336.46 Mn
Dec 31, 2021 368.20 Mn
Sep 30, 2021 414.12 Mn
API Access

Dyne Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=DYN&period=max&api_key=YOUR_API_KEY